Next-generation genotyping by digital PCR to detect and quantify the BRAF V600E mutation in melanoma biopsies

Journal of Molecular Diagnostics

Volumn 17, Issue 4, 2015, Pages 366-373

  Lamy, Pierre Jean ^a   Castan, Florence ^a   Lozano, Nicolas ^a   Montélion, Cécile ^a   Audran, Patricia ^a   Bibeau, Frédéric ^a   Roques, Sylvie ^a   Montels, Frédéric ^a   Laberenne, Anne Claire ^a  

^a CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; B RAF KINASE INHIBITOR; NUCLEIC ACID; BRAF PROTEIN, HUMAN; DNA;

ALLELE; ARTICLE; CANCER PATIENT; COMPARATIVE STUDY; CUTANEOUS MELANOMA; DNA EXTRACTION; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LIMIT OF DETECTION; LNCAP CELL LINE; MELANOMA; METASTATIC MELANOMA; MICROFLUIDICS; NEXT GENERATION SEQUENCING; POLYMERASE CHAIN REACTION; PYROSEQUENCING; SOMATIC MUTATION; TUMOR BIOPSY; BIOPSY; GENETICS; HIGH THROUGHPUT SEQUENCING; MUTATION; NUCLEOTIDE SEQUENCE; PROCEDURES; SKIN NEOPLASMS;

BIOPSY; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MELANOMA; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS;

EID: 84931350052     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.02.004     Document Type: Article

References (25)

1. H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, and S. Clegg Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
2. E. Tiacci, V. Trifonov, G. Schiavoni, A. Holmes, W. Kern, M.P. Martelli, A. Pucciarini, B. Bigerna, R. Pacini, V.A. Wells, P. Sportoletti, V. Pettirossi, R. Mannucci, O. Elliott, A. Liso, A. Ambrosetti, A. Pulsoni, F. Forconi, L. Trentin, G. Semenzato, G. Inghirami, M. Capponi, F. De Raimondo, C. Patti, L. Arcaini, P. Musto, S. Pileri, C. Haferlach, S. Schnittger, G. Pizzolo, R. Foa, L. Farinelli, T. Haferlach, L. Pasqualucci, R. Rabadan, and B. Falini BRAF mutations in hairy-cell leukemia N Engl J Med 364 2011 2305 2315
3. M. Sobrinho-Simoes, A. Preto, A.S. Rocha, P. Castro, V. Maximo, E. Fonseca, and P. Soares Molecular pathology of well-differentiated thyroid carcinomas Virchows Arch 447 2005 787 793
4. W.O. Greaves, S. Verma, K.P. Patel, M.A. Davies, B.A. Barkoh, J.M. Galbincea, H. Yao, A.J. Lazar, K.D. Aldape, L.J. Medeiros, and R. Luthra Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma J Mol Diagn 15 2013 220 226
5. M.C. Ravnan, and M.S. Matalka Vemurafenib in patients with BRAF V600E mutation-positive advanced melanoma Clin Ther 34 2012 1474 1486
6. C. Swanton Intratumor heterogeneity: evolution through space and time Cancer Res 72 2012 4875 4882
7. M. Gerlinger, A.J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, I. Varela, B. Phillimore, S. Begum, N.Q. McDonald, A. Butler, D. Jones, K. Raine, C. Latimer, C.R. Santos, M. Nohadani, A.C. Eklund, B. Spencer-Dene, G. Clark, L. Pickering, G. Stamp, M. Gore, Z. Szallasi, J. Downward, P.A. Futreal, and C. Swanton Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883 892
8. S.P. Shah, A. Roth, R. Goya, A. Oloumi, G. Ha, and Y. Zhao The clonal and mutational evolution spectrum of primary triple-negative breast cancers Nature 486 2012 395 399
9. D. Gonzalez de Castro, B. Angulo, B. Gomez, D. Mair, R. Martinez, A. Suarez-Gauthier, F. Shieh, M. Velez, V.H. Brophy, H.J. Lawrence, and F. Lopez-Rios A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens Br J Cancer 107 2012 345 351
10. P.J. Sykes, S.H. Neoh, M.J. Brisco, E. Hughes, J. Condon, and A.A. Morley Quantitation of targets for PCR by use of limiting dilution Biotechniques 13 1992 444 449
11. B.J. Hindson, K.D. Ness, D.A. Masquelier, P. Belgrader, N.J. Heredia, and A.J. Makarewicz High-throughput droplet digital PCR system for absolute quantitation of DNA copy number Anal Chem 83 2011 8604 8610
12. I. Yeh, A. von Deimling, and B.C. Bastian Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia J Natl Cancer Inst 105 2013 917 919
13. F. Bizouarn Clinical applications using digital PCR Methods Mol Biol 1160 2014 189 214
14. L. Warren, D. Bryder, I.L. Weissman, and S.R. Quake Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR Proc Natl Acad Sci U S A 103 2006 17807 17812
15. D. Dressman, H. Yan, G. Traverso, K.W. Kinzler, and B. Vogelstein Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations Proc Natl Acad Sci U S A 100 2003 8817 8822
16. N.R. Beer, B.J. Hindson, E.K. Wheeler, S.B. Hall, K.A. Rose, I.M. Kennedy, and B.W. Colston On-chip, real-time, single-copy polymerase chain reaction in picoliter droplets Anal Chem 79 2007 8471 8475
17. J.H. Lee, J.W. Choi, and Y.S. Kim Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis Br J Dermatol 164 2011 776 784
18. J. Lade-Keller, K.M. Romer, P. Guldberg, R. Riber-Hansen, L.L. Hansen, T. Steiniche, H. Hager, and L.S. Kristensen Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas J Mol Diagn 15 2013 70 80
19. F. Lopez-Rios, B. Angulo, B. Gomez, D. Mair, R. Martinez, E. Conde, F. Shieh, J. Vaks, R. Langland, H.J. Lawrence, and D.G. de Castro Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib PLoS One 8 2013 e53733
20. E. Colomba, Z. Helias-Rodzewicz, A. Von Deimling, C. Marin, N. Terrones, D. Pechaud, S. Surel, J.F. Cote, F. Peschaud, D. Capper, H. Blons, U. Zimmermann, T. Clerici, P. Saiag, and J.F. Emile Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing J Mol Diagn 15 2013 94 100
21. L. Heinzerling, M. Baiter, S. Kuhnapfel, G. Schuler, P. Keikavoussi, A. Agaimy, F. Kiesewetter, A. Hartmann, and R. Schneider-Stock Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations Br J Cancer 109 2013 2833 2841
22. A.M. Menzies, J.S. Wilmott, G.V. Long, and R.A. Scolyer Intra-patient heterogeneity of BRAF mutation status: fact or fiction? Br J Cancer 111 2014 1678 1679
23. H. Halait, K. Demartin, S. Shah, S. Soviero, R. Langland, S. Cheng, G. Hillman, L. Wu, and H.J. Lawrence Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma Diagn Mol Pathol 21 2012 1 8
24. F. Su, A. Viros, C. Milagre, K. Trunzer, G. Bollag, and O. Spleiss RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors N Engl J Med 366 2012 207 215
25. A.R. Thierry, F. Mouliere, S. El Messaoudi, C. Mollevi, E. Lopez-Crapez, F. Rolet, B. Gillet, C. Gongora, P. Dechelotte, B. Robert, M. Del Rio, P.J. Lamy, F. Bibeau, M. Nouaille, V. Loriot, A.S. Jarrousse, F. Molina, M. Mathonnet, D. Pezet, and M. Ychou Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA Nat Med 20 2014 430 435